Publicaciones en las que colabora con CRISTINA MARTÍN SABROSO (15)

2023

  1. Capacitación de alumnos de pregrado en la generación de contenidos divulgativos de Farmacia y Tecnología Farmacéutica para su difusión en entornos virtuales

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Celecoxib-loaded PLGA nanoparticles for the treatment ofrheumatoid arthritis: in ovo assessment of theirantiangiogenic effect

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Design of dosage forms: influences of anatomy and administration routes

    Dosage Forms, Formulation Developments and Regulations: Recent and Future Trends in Pharmaceutics, Volume 1 (Elsevier), pp. 183-221

  4. XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

    Sociedad Española de Farmacia Industrial y Galénica

2022

  1. Active targeted nanoformulations via folate receptors: State of the art and future perspectives

    Pharmaceutics, Vol. 14, Núm. 1

  2. Aplicación de las TIC en asignaturas teórico-prácticas del grado en Farmacia: tecnología farmacéutica y biofarmacia y farmacocinética

    Jornada «Aprendizaje Eficaz con TIC en la UCM» (Universidad Complutense de Madrid), pp. 43-53

  3. Current status of nanomedicine for breast cancer treatment

    Targeted Nanomedicine for Breast Cancer Therapy (Elsevier), pp. 65-110

  4. DoE-based development of celecoxib loaded PLGA nanoparticles: In ovo assessment of its antiangiogenic effect

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 180, pp. 149-160

  5. Limitations and challenges in the stability of cysteamine eye drop compounded formulations

    Pharmaceuticals, Vol. 15, Núm. 1

2020

  1. CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer

    International Journal of Pharmaceutics, Vol. 574

  2. Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 246-258

  3. PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: In vitro and in Ovo assessment

    Pharmaceutics, Vol. 12, Núm. 5

  4. Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1150

2019

  1. Adquisición de competencias transversales mediante debates asíncronos: Diseño e implementación en las enseñanzas de tecnología farmacéutica

    Innovación Docente e Investigación en Ciencias de la Salud (Dykinson), pp. 309-320

  2. Current status of nanomedicine in the chemotherapy of breast cancer

    Cancer Chemotherapy and Pharmacology, Vol. 84, Núm. 4, pp. 689-706